Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

Core Insights - Natural Alternatives International, Inc. reported a net loss of $2.2 million, or $0.37 per diluted share, on net sales of $28.8 million for Q3 FY 2025, compared to a net loss of $1.6 million, or $0.27 per diluted share, in the same quarter of the previous fiscal year [1][3][12]. Financial Performance - Net sales for the three months ended March 31, 2025, increased by $3.6 million, or 14%, to $28.8 million compared to $25.1 million in the same period last year [2][4]. - For the nine months ended March 31, 2025, net sales rose by $11.7 million, or 14%, to $96.0 million from $84.3 million in the prior year [4]. - Private-label contract manufacturing sales increased by 20% to $27.1 million in Q3 FY 2025 and by 16% to $90.0 million for the nine months ended March 31, 2025 [2][4]. Revenue Breakdown - CarnoSyn beta-alanine royalty, licensing, and raw material sales revenue decreased by 36% to $1.7 million in Q3 FY 2025, down from $2.7 million in Q3 FY 2024 [3]. - For the first nine months of FY 2025, CarnoSyn revenue decreased by 9% to $6.0 million compared to $6.6 million in the same period of FY 2024 [4]. Operational Challenges - The company experienced a loss from operations primarily due to underutilization of factory capacities, lower beta-alanine revenue, and increased operating expenses related to legal costs and salaries [5]. - Manufacturing costs were negatively impacted by increased labor, foreign currency exchange rates, operating supplies, rent, and freight costs [5]. Cash and Working Capital - As of March 31, 2025, the company had cash of $10.6 million and working capital of $35.2 million, down from $12.0 million and $38.1 million respectively as of June 30, 2024 [6][14]. Management Commentary - The CEO expressed optimism about continued revenue growth and the potential for profitability in the upcoming year, despite challenges from supply chain issues and currency valuations [7]. - The company is also encouraged by interest in its new TriBsyn™ product offering, with plans for commercial launches in retail channels [7]. Company Overview - Natural Alternatives International, Inc. is a leading formulator, manufacturer, and marketer of customized nutritional supplements, providing a wide range of services including scientific research, product formulation, and regulatory review [8].